Global Lipid Nanoparticle CDMO Market to Reach USD 1.17 Billion by 2035 at 14.59% CAGR as RNA Therapeutics Outsourcing Accelerates | SNS Insider

The U.S. Lipid Nanoparticle CDMO Market is projected to reach USD 0.44 billion by 2035, while Europe is expected to reach USD 0.27 billion, driven by expanding mRNA, siRNA, gene-editing therapeutics, and GMP manufacturing investments.

The U.S. Lipid Nanoparticle CDMO Market is projected to reach USD 0.44 billion by 2035, while Europe is expected to reach USD 0.27 billion, driven by expanding mRNA, siRNA, gene-editing therapeutics, and GMP manufacturing investments.